Avastin, which prevents blood-vessel growth, is used to treat both wet age-related macular degeneration in the eye and for cancer.
The VA decision comes after FDA advisers rejected using the drug in breast cancer because of the risk of deadly bleeding. Also, macular degeneration patients at a VA facility in Los Angeles were blinded after being injected with the drug.
Related Articles on Avastin:
Four Patients Become Victims of Contaminated Shots at Tennessee VA Facility
Five More Patients Blinded by Drug in Los Angeles VA Hospital
FDA: Repackaged Avastin Caused Eye Infections in Florida
